Lantheus Holdings (LNTH) Accounts Payables (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Accounts Payables of $45.9 million for Q1 2026, up 2.23% year-over-year from $44.9 million in Q1 2025, and up 6.92% quarter-over-quarter from $42.9 million in Q4 2025.
Lantheus Holdings (LNTH) Accounts Payables (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Accounts Payables for 13 consecutive years, with $45.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables rose 2.23% year-over-year to $45.9 million; the TTM figure through Mar 2026 stood at $45.9 million (up 2.23% YoY), while the FY2025 annual figure was $42.9 million, up 24.15% from the prior year.
- Accounts Payables grew to $45.9 million in Q1 2026 per LNTH's latest filing, from $42.9 million in the prior quarter.
- Across five years, Accounts Payables topped out at $66.3 million in Q3 2025 and bottomed at $20.6 million in Q4 2022.
- Historically, Accounts Payables has averaged $38.2 million across 5 years, with a median of $38.9 million in 2023.
- Annual changes were most pronounced in 2023 — Accounts Payables jumped 100.31% — and 2025, when it fell 17.85%.
- Lantheus Holdings' Accounts Payables stood at $20.6 million in 2022, then soared by 100.31% to $41.2 million in 2023, then declined by 16.09% to $34.6 million in 2024, then advanced by 24.15% to $42.9 million in 2025, then advanced by 6.92% to $45.9 million in 2026.
- Business Quant data shows LNTH's Accounts Payables at $45.9 million in Q1 2026, $42.9 million in Q4 2025, and $66.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.18 Bn | 43.22 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.96 Bn | 40.30 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 32.59 Bn | 30.92 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.33 Bn | 19.67 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.90 Bn | 18.01 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.59 Bn | 15.20 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.95 Bn | 11.42 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.98 Bn | - | 356.00 Mn |
| 10 | Lantheus Holdings | 6.53 Bn | 5.93 Bn | 241.86 Mn | 48.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 48.11 Mn |
| Mar 31, 2026 | 45.88 Mn |
| Dec 31, 2025 | 42.91 Mn |
| Sep 30, 2025 | 66.30 Mn |
| Jun 30, 2025 | 40.89 Mn |
| Mar 31, 2025 | 44.87 Mn |
| Dec 31, 2024 | 34.56 Mn |
| Sep 30, 2024 | 44.91 Mn |
| Jun 30, 2024 | 49.77 Mn |
| Mar 31, 2024 | 37.53 Mn |
| Dec 31, 2023 | 41.19 Mn |
| Sep 30, 2023 | 37.08 Mn |
| Jun 30, 2023 | 38.86 Mn |
| Mar 31, 2023 | 30.80 Mn |
| Dec 31, 2022 | 20.56 Mn |
| Sep 30, 2022 | 30.14 Mn |
| Jun 30, 2022 | 21.15 Mn |
| Mar 31, 2022 | 22.38 Mn |
| Dec 31, 2021 | 20.79 Mn |
| Sep 30, 2021 | 20.51 Mn |